XML 51 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS, NET (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Finite-Lived Intangible Assets    
Accumulated Amortization $ (184,641) $ (146,081)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 2,303,019 1,761,332
Net Amount 2,118,378 1,615,251
Hormone Therapy Drug Candidate Patents - (Pending) [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 1,037,829 774,165
Net Amount 1,037,829 774,165
Multiple Trademarks [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 182,437 157,721
Net Amount 182,437 157,721
Opera Software Patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (5,991) (4,493)
Net Amount $ 25,960 $ 27,458
Weighted average remaining amortization period 13 years 13 years 9 months
Development Costs Of Corporate Website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization (91,743) (91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 959,059 705,752
Accumulated Amortization (86,907) (49,845)
Net Amount $ 872,152 $ 655,907
Weighted average remaining amortization period 16 years 3 months 17 years